Literature DB >> 20326829

Clinical Study of a Potent Antidepressant, Tranylcypromine with Trifluorperazine (Parstelin ), in the Aged Chronically Ill.

M Straker, H Grauer.   

Abstract

Entities:  

Year:  1961        PMID： 20326829      PMCID： PMC1848140     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Depressive reactions in the aged chronically ill.

Authors:  M STRAKER
Journal:  Can Med Assoc J       Date:  1959-12-01       Impact factor: 8.262

2.  Dual action therapy in depressive symptoms.

Authors:  J B HAYES
Journal:  J Neuropsychiatr       Date:  1960 Sep-Oct

3.  Depressive states and theirborderlands: classification, diagnosis and treatment.

Authors:  M ROTH
Journal:  Compr Psychiatry       Date:  1960-06       Impact factor: 3.735

4.  Clinical Evaluation of a New Antidepressant Agent: Tranylcypromine with Trifluoperazine (Parstelin).

Authors:  M Straker
Journal:  Can Med Assoc J       Date:  1960-12-17       Impact factor: 8.262

5.  Recent Trends in Psychiatric Management.

Authors:  R B Sloane
Journal:  Can Med Assoc J       Date:  1960-11-19       Impact factor: 8.262

6.  Tranylcypromine (parnate) a new monoamine oxidase inhibitor.

Authors:  F LEMERE
Journal:  Am J Psychiatry       Date:  1960-09       Impact factor: 18.112
  6 in total
  1 in total

1.  Combinations of Pharmaceuticals.

Authors:  D S Robertson
Journal:  Can Med Assoc J       Date:  1961-09-16       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.